Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Research ArticleOriginal Research

Overall Survival Associated With Ileostomy Closure in Patients With Rectal Cancer Before and After Adjuvant Therapy

Shaun R. Brown, Behram Khan, Heather J. Green and David E. Beck
Ochsner Journal December 2017, 17 (4) 328-330;
Shaun R. Brown
1Department of Colon and Rectal Surgery, William Beaumont Medical Center, El Paso, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Behram Khan
2Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather J. Green
3Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David E. Beck
3Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA
4The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: A diverting loop ileostomy is commonly constructed to protect a distal anastomosis after proctectomy for rectal cancer. Little data are available on whether closing the ileostomy before or after adjuvant chemotherapy affects survival.

Methods: We conducted a retrospective review of patients with rectal cancer who underwent a low anterior resection with diverting loop ileostomy followed by adjuvant chemotherapy at Ochsner Medical Center. The primary outcome was the long-term survival in patients who had their loop ileostomies closed before chemotherapy (BC) vs after chemotherapy (AC).

Results: Seventy-two patients were identified (22 in the BC group vs 50 in the AC group). No difference in mean age (BC 59.5 ± 9.8 vs AC 59.2 ± 12.6, P=0.9) or preoperative clinical stage was seen between study groups. The mean interval from ileostomy creation to closure was significantly shorter in the BC group vs AC group (16.9 ± 14.5 weeks vs 33.6 ± 18.1 weeks, P=0.0001). Follow-up data revealed a similar mean duration from surgery to last contact (BC 50.6 ± 23.6 months vs AC 43.5 ± 22.1 months, P=0.23) and similar overall survival (BC 86% vs AC 70%, P=0.23) between groups.

Conclusion: Long-term survival was similar in patients who underwent ileostomy closure before and after adjuvant therapy following low anterior resection for rectal cancer. While this study was underpowered, it adds additional insight to an area of surgery lacking significant data. The timing of ileostomy closure should be individualized for each patient.

Keywords
  • Chemotherapy
  • ileostomy
  • ileostomy closure
  • rectal neoplasm
  • surgical stomas

INTRODUCTION

A diverting ileostomy is often created following low anterior resection for rectal cancer to reduce anastomotic complications. However, the construction of an ileostomy is not without complications, and its presence may reduce the quality of life for patients.1,2 The common clinical scenario for patients with stage II or greater rectal cancer includes preoperative (neoadjuvant) chemoradiation therapy, surgical resection, and ileostomy creation, followed by a 6-month course of postoperative (adjuvant) chemotherapy.3,4 Typically, the ileostomy is left in place until after completion of the adjuvant therapy, at which time the stoma is closed. This delay in closure for up to 6-8 months following surgery may have significant adverse implications for patients in terms of their quality of life. On the other hand, if the ileostomy is closed prior to adjuvant therapy, the initiation of treatment following surgical resection may be delayed until the patient has recovered from both operations. This delay may affect the patient's survival. The purpose of this study was to compare long-term survival of patients with rectal cancer who had their ileostomy closed before chemotherapy (BC) vs after chemotherapy (AC).

METHODS

We conducted a retrospective review of a prospectively collected database of patients with rectal cancer who underwent definitive care at a tertiary care facility. All patients included in this study underwent a low anterior resection with diverting loop ileostomy from 2005-2013. Patients were divided into 2 groups: those who had their ileostomy closed BC and those who had their stoma closed AC. The decision of when to close the ileostomy was made between the surgeon and patient. Neoadjuvant chemotherapy along with radiation therapy is indicated in patients with T3/T4 tumors or evidence of lymph node positivity based on preoperative imaging (pelvic magnetic resonance imaging in this cohort).

Patient demographic information collected from the records included age, preoperative clinical stage (clinical tumor/node/metastasis classification), and postoperative pathologic stage. Neoadjuvant and adjuvant therapies were compared between groups. Time from the initial surgery to the date of ileostomy closure was calculated in weeks. Time from initial surgery to the date of last contact was calculated in months. The vital status (alive vs dead) was recorded at the time of the last contact. Date of last contact was either the date of the last office visit or a telephone inquiry with the patient's family via the tumor registry. The duration in months from the time of surgery to the date of last contact and the vital status were used to calculate the long-term survival for each patient.

For statistical analysis, t test and chi-square analysis were used to compare discrete and continuous variables, respectively, and P<0.05 was considered statistically significant. A Kaplan-Meier curve was calculated to compare survival between groups. Statistical analysis was performed with SPSS statistical software, v.20 (IBM Corp).

RESULTS

A total of 72 patients were included in this analysis: 22 patients who underwent ileostomy closure BC and 50 patients with closure AC. Study participants were similar in age in both groups (BC group mean age of 59.5 ± 9.8 years vs 59.2 ± 12.6 years in the AC group, P=0.9) (Table). The pathologic stage following resection was similar between groups. Neoadjuvant therapy was given to the majority of patients in each study group. Twenty-one of 22 patients (95%) in the BC group and 47 of 50 patients (94%) in the AC group received neoadjuvant therapy, P=0.9. The mean interval from ileostomy creation to closure was significantly shorter in the BC group vs AC group (16.9 ± 14.5 weeks vs 33.6 ± 18.1, P=0.0001). The mean duration from surgery to last contact was similar between the study groups (BC 50.6 ± 23.6 months vs AC 43.5 ± 22.1 months, P=0.23). Additionally, the number of patients alive at the date of last contact was similar between groups (BC 19 [86%] vs AC 35 [70%], P=0.23) (Figure 1). The Kaplan Meier curve favored closure BC, but the results failed to reach statistical significance (Figure 2).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table.

Patient Demographics by Ileostomy Closure Timing

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Overall survival of ileostomy closure before chemotherapy vs after chemotherapy, P=0.23.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Kaplan-Meier curve: Closure before chemotherapy=1, closure after chemotherapy=0, P=0.124.

DISCUSSION

This analysis demonstrates that overall survival was similar between patients who underwent ileostomy closure before vs after adjuvant chemotherapy. Ileostomy-related complications are not insignificant and may occur in 10%-75% of patients.1,5,6 Complications include parastomal hernia, obstruction, high output with excessive fluid loss, and skin rash and are more prevalent in patients who receive neoadjuvant or adjuvant therapy. On the other hand, ileostomy closure is also associated with complications. Ileostomy closure is associated with a complication rate of 17.2%, with small bowel obstruction being the most common complication.7 The optimal timing of ileostomy closure in regard to morbidity remains unknown. Perez et al demonstrated an increase in ileostomy closure complications when the stoma was closed <8.5 weeks following ileostomy creation.7 However, a randomized clinical trial of early ileostomy closure (8 days) vs late ileostomy closure (2 months) demonstrated similar rates of morbidity for each study group.8 Consequently, whether the timing of ileostomy closure relative to adjuvant chemotherapy has an impact on complications or survival for the patient remains unclear. While the quality of life for the patient may be improved with closure prior to the start of adjuvant chemotherapy, a complication related to the closure will likely delay treatment.

Our study specifically looked at the long-term survival in patients with rectal cancer in relation to the timing of ileostomy closure. These results add to the current data about diverting loop ileostomy closure in relation to adjuvant chemotherapy. This important clinical issue is currently underrepresented in the surgical literature. Further studies are needed to evaluate the optimal timing of ileostomy closure for disease-free survival and overall survival for patients with rectal cancer.

One of the limitations of this analysis is that it was underpowered to demonstrate a difference >20%. Therefore, whether there is any real difference in survival is unclear, but for this cohort of patients, survival appears to be similar. In addition, the interval between ileostomy creation and the start of chemotherapy is an important consideration. However, because of limitations in the dataset and the fact that a significant number of patients received adjuvant chemotherapy at outside facilities following surgical resection, this interval could not be calculated with any level of accuracy.

CONCLUSION

The results of this study demonstrate similar overall survival in patients who underwent ileostomy closure before vs after adjuvant therapy following low anterior resection for rectal cancer. While this study was underpowered, it adds insight to an area of surgery lacking significant data. Until such data are available, the timing of ileostomy closure should be individualized for each patient.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care, Medical Knowledge, and Practice-Based Learning and Improvement.

ACKNOWLEDGMENTS

The authors have no financial or proprietary interest in the subject matter of this article.

  • © Academic Division of Ochsner Clinic Foundation 2017

REFERENCES

  1. 1.↵
    1. Kaidar-Person O,
    2. Person B,
    3. Wexner SD
    Complications of construction and closure of temporary loop ileostomy. J Am Coll Surg. 2005 11; 201 5: 759- 773. pmid:16256921
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Thalheimer A,
    2. Bueter M,
    3. Kortuem M,
    4. Thiede A,
    5. Meyer D
    Morbidity of temporary loop ileostomy in patients with colorectal cancer. Dis Colon Rectum. 2006 7; 49 7: 1011- 1017. pmid:16598401
    OpenUrlPubMed
  3. 3.↵
    1. Benson AB 3rd,.,
    2. Bekaii-Saab T,
    3. Chan E,
    4. et al.
    Rectal cancer. J Natl Compr Canc Netw. 2012 12 1; 10 12: 1528- 1564. pmid:23221790
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Schmoll HJ,
    2. Van Cutsem E,
    3. Stein A,
    4. et al.
    ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012 10; 23 10: 2479- 2516. pmid:23012255
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Park JJ,
    2. Del Pino A,
    3. Orsay CP,
    4. et al.
    Stoma complications: the Cook County Hospital experience. Dis Colon Rectum. 1999 12; 42 12: 1575- 1580. pmid:10613476
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Gooszen AW,
    2. Geelkerken RH,
    3. Hermans J,
    4. Lagaay MB,
    5. Gooszen HG
    Temporary decompression after colorectal surgery: randomized comparison of loop ileostomy and loop colostomy. Br J Surg. 1998 1; 85 1: 76- 79. pmid:9462389
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Perez RO,
    2. Habr-Gama A,
    3. Seid VE,
    4. et al.
    Loop ileostomy morbidity: timing of closure matters. Dis Colon Rectum. 2006 10; 49 10: 1539- 1545. pmid:16897328
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Alves A,
    2. Panis Y,
    3. Lelong B,
    4. Dousset B,
    5. Benoist S,
    6. Vicaut E
    Randomized clinical trial of early versus delayed temporary stoma closure after proctectomy. Br J Surg. 2008 6; 95 6: 693- 698. doi: 10.1002/bjs.6212. pmid:18446781
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 17, Issue 4
Dec 2017
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Overall Survival Associated With Ileostomy Closure in Patients With Rectal Cancer Before and After Adjuvant Therapy
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Overall Survival Associated With Ileostomy Closure in Patients With Rectal Cancer Before and After Adjuvant Therapy
Shaun R. Brown, Behram Khan, Heather J. Green, David E. Beck
Ochsner Journal Dec 2017, 17 (4) 328-330;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Overall Survival Associated With Ileostomy Closure in Patients With Rectal Cancer Before and After Adjuvant Therapy
Shaun R. Brown, Behram Khan, Heather J. Green, David E. Beck
Ochsner Journal Dec 2017, 17 (4) 328-330;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Cited By...

  • Tolerability and Adverse Events of Adjuvant Chemotherapy for Rectal Cancer in Patients With Diverting Ileostomy
  • Google Scholar

More in this TOC Section

  • Differential Impact of Body Mass Index in Hip Arthroscopy: Obesity Does Not Impact Outcomes
  • Adductor Canal Blocks Are Not Associated With Improved Early Postoperative Outcomes in Patients Undergoing Total Knee Arthroplasty
  • Revision Carpal Tunnel Release With Umbilical Cord Allograft: A Four-Year Retrospective Cohort Study
Show more ORIGINAL RESEARCH

Similar Articles

Keywords

  • Chemotherapy
  • Ileostomy
  • ileostomy closure
  • rectal neoplasm
  • surgical stomas

Current Post at the Blog

American Association for the Advancement of Science Surveys Scientists About Article Publishing Charges—And Uncovers More Problems

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2023 Ochsner Clinic Foundation

Powered by HighWire